SANDOZ CREIGHTON SUBSIDIARY GAINS FIRST GENERIC CLOZARIL APPROVAL; 3M MINITRANNOW EQUIVALENT TO SCHERING's NITRO-DUR; MYLAN NITROGLYCERIN PATCH APPROVED
Executive Summary
Sandoz' Creighton Products subsidiary receives "first generic" approval for the parent company's anti-psychotic drug Clozaril. The ANDA for clozapine 25 mg and 100 mg tablets was approved on Aug. 30.